Evolocumab vs. Ezetimibe in Addition to Statins for Secondary Prevention of Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Hypercholesterolemia.

被引：0
|
作者：
Azuri, Joseph [1 ]
Hammerman, Ariel [2 ]
Arbel, Ronen [3 ]
机构：
[1] Tel Aviv Univ, Family Med, Sackler Fac Med, Tel Aviv, Israel
[2] Clalit Hlth Serv, Med, Tel Aviv, Israel
[3] Sapir Coll, Med, Sderot, Israel
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Diabetes (Type II); Endpoint events; LDL; PCSK9; Efficacy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12027
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Semaglutide Provides More Value for Money Than Dulaglutide or Liraglutide for Prevention of Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease
    Azuri, Joseph
    Aboalhasan, Enis
    Hammerman, Ariel
    Arbel, Ronen
    CIRCULATION, 2020, 142
  • [32] Cost-Effectiveness of Atorvastatin in the Primary Prevention of Major Cardiovascular Events in Patients with Type 2 Diabetes in Canada
    Khoury, Hanane
    Wagner, Monika
    Merikle, Elizabeth
    Johnson, Scott J.
    Roberts, Craig
    CANADIAN JOURNAL OF DIABETES, 2009, 33 (04) : 363 - 374
  • [33] Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes
    Baker, William L.
    Beyer-Westendorf, Jan
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Sood, Nitesh A.
    Coleman, Craig I.
    DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2107 - 2114
  • [34] Type 2 Diabetes and Risk of Cardiovascular Events in Peripheral Artery Disease vs. Coronary Artery Disease Patients
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Klement, Margaretha
    Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2020, 69
  • [35] Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
    Xing, Zhenhua
    Peng, Zhenyu
    Wang, Xiaopu
    Zhu, Zhaowei
    Pei, Junyu
    Hui, Xinqun
    Chai, Xiangping
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [36] The first harmonic of radial pulse wave predicts major adverse cardiovascular and microvascular events in patients with type 2 diabetes
    Liao, Kuo-Meng
    Chang, Chi-Wei
    Wang, Sheng-Hung
    Chang, Yi-Ting
    Chen, Ying-Chun
    Wang, Gin-Chung
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (11)
  • [37] Epicardial adipose tissue volume predicts long term major adverse cardiovascular events in patients with Type 2 diabetes
    Uygur, Begum
    Celik, Omer
    Demir, Ali Riza
    Karakayali, Muammer
    Arslan, Cagdas
    Temur, Hafize Otcu
    Alis, Deniz
    Yildirim, Ceren
    Corekcioglu, Busra
    Erturk, Mehmet
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2021, 49 (02): : 127 - 134
  • [38] Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
    Zhenhua Xing
    Zhenyu Peng
    Xiaopu Wang
    Zhaowei Zhu
    Junyu Pei
    Xinqun Hu
    Xiangping Chai
    Cardiovascular Diabetology, 19
  • [39] Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes
    Abdelmoneim, Ahmed S.
    Eurich, Dean T.
    Senthilselvan, Ambikaipakan
    Qiu, Weiyu
    Simpson, Scot H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (10) : 1186 - 1195
  • [40] New evidence on the prevention of cardiovascular events in hypertensive patients with type 2 diabetes
    Pahor, M
    Psaty, BM
    Furberg, CD
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 : S18 - S23
12345